Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics

10 Aug 2005

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Disease Management and Epidemiology
Share to Influenza Virus Research Studies
Share to Viral gastroenteritis research and epidemiology

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 16084554
DOI: 10.1016/j.virol.2005.07.011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse geneticsPMID 16084554Read ↗

The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickensSemantic proximity Read ↗

Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse geneticsSemantic proximity Read ↗

Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenzaSemantic proximity Read ↗

Immunization with a novel RNA replicon vaccine confers long-lasting protection against H5N1 avian influenza virus in 24 bird speciesSemantic proximity Read ↗

Modification of the avian coronavirus infectious bronchitis virus for vaccine developmentSemantic proximity Read ↗

Reverse Genetics for Newcastle Disease Virus as a Vaccine VectorSemantic proximity Read ↗

Protective Efficacy of an H5N1 Inactivated Vaccine Against Challenge with Lethal H5N1, H5N2, H5N6, and H5N8 Influenza Viruses in ChickensSemantic proximity Read ↗

Recombinant Newcastle disease virus as a vaccine vectorSemantic proximity Read ↗

Vaccines Developed for H5 Highly Pathogenic Avian Influenza in ChinaSemantic proximity Read ↗

Development of DIVA (differentiation of infected from vaccinated animals) vaccines utilizing heterologous NA and NS1 protein strategies for the control of triple reassortant H3N2 influenza in turkeysSemantic proximity Read ↗

Pathogenic potential of North American H7N2 avian influenza virus: A mutagenesis study using reverse geneticsSemantic proximity Read ↗

Vectored vaccines to protect against PRRSVSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.